Cargando…

Regulation of Cisplatin Resistance in Lung Cancer Cells by Nicotine, BDNF, and a β-Adrenergic Receptor Blocker

It is well-recognized that cigarette smoking is a primary risk factor in the development of non-small cell lung cancer (NSCLC), known to account for ~80% of all lung cancers with nicotine recognized as the major addictive component. In investigating the effect of nicotine, brain-derived neurotrophic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ray, Ravel, Al Khashali, Hind, Haddad, Ben, Wareham, Jadziah, Coleman, Kai-Ling, Alomari, Danyah, Ranzenberger, Robert, Guthrie, Jeffrey, Heyl, Deborah, Evans, Hedeel Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657603/ https://www.ncbi.nlm.nih.gov/pubmed/36361620 http://dx.doi.org/10.3390/ijms232112829

Ejemplares similares

Regulation of Soluble E-Cadherin Signaling in Non-Small-Cell Lung Cancer Cells by Nicotine, BDNF, and β-Adrenergic Receptor Ligands
por: Ray, Ravel, et al.
Publicado: (2023)

Opposing Roles of IGFBP-3 and Heparanase in Regulating A549 Lung Cancer Cell Survival
por: Al Khashali, Hind, et al.
Publicado: (2022)

Regulation of the Soluble Amyloid Precursor Protein α (sAPPα) Levels by Acetylcholinesterase and Brain-Derived Neurotrophic Factor in Lung Cancer Cell Media
por: Al Khashali, Hind, et al.
Publicado: (2022)

Differences in the Relative Abundance of ProBDNF and Mature BDNF in A549 and H1299 Human Lung Cancer Cell Media
por: Dorandish, Sadaf, et al.
Publicado: (2021)

Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance
por: Coleman, Kai-ling, et al.
Publicado: (2023)

IGFBP-3 Blocks Hyaluronan-CD44 Signaling, Leading to Increased Acetylcholinesterase Levels in A549 Cell Media and Apoptosis in a p53-Dependent Manner
por: Price, Deanna, et al.
Publicado: (2020)

Biochemical determinants of the IGFBP‐3–hyaluronan interaction
por: Dorandish, Sadaf, et al.
Publicado: (2020)

Interaction of amyloid beta with humanin and acetylcholinesterase is modulated by ATP
por: Atali, Sarah, et al.
Publicado: (2020)

Regulation of amyloid-β levels by matrix metalloproteinase-2/9 (MMP2/9) in the media of lung cancer cells
por: Dorandish, Sadaf, et al.
Publicado: (2021)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

Does atenolol differ from other β-adrenergic blockers?
por: Aursnes, Ivar, et al.
Publicado: (2007)

Can beta-adrenergic blockers be used in the treatment of COVID-19?
por: Vasanthakumar, Natesan
Publicado: (2020)

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)

A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure
por: Zhang, Xiaojian, et al.
Publicado: (2016)

Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients
por: Berends, Annika M. A., et al.
Publicado: (2022)

The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms
por: quốc Lu’o’ng, Khanh vinh, et al.
Publicado: (2012)

Adverse effects of beta adrenergic blockers during spinal anesthesia with 0.5% bupivacaine
por: Vukelić, J, et al.
Publicado: (2010)

Meta-Analysis of the Safety and Efficacy of α-Adrenergic Blockers for Pediatric Urolithiasis in the Distal Ureter
por: Sun, Fengze, et al.
Publicado: (2022)

The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury
por: Nurlu Temel, Esra, et al.
Publicado: (2023)

BDNF/TRK/KCC2 pathway in nicotine withdrawal-induced hyperalgesia
por: Shi, Wenhui, et al.
Publicado: (2015)

α(2)-Adrenergic Disruption of β Cell BDNF-TrkB Receptor Tyrosine Kinase Signaling
por: Kalwat, Michael A., et al.
Publicado: (2020)

Clinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope – a meta-analysis
por: Vallurupalli, Srikanth, et al.
Publicado: (2010)

The use of alpha-1 adrenergic blockers in children with distal ureterolithiasis: a systematic review and meta-analysis
por: Glina, F.P., et al.
Publicado: (2015)

Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy
por: Reddy, Sushma, et al.
Publicado: (2015)

Effect of adrenergic blockers, carvedilol, prazosin, metoprolol and combination of prazosin and metoprolol on paracetamol-induced hepatotoxicity in rabbits
por: Zubairi, Maysaa B., et al.
Publicado: (2014)

Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma
por: Rossi, Maïlys, et al.
Publicado: (2022)

Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review
por: Brewster, Lizzy M, et al.
Publicado: (2013)

Dysregulated Methylation Patterns in Exon IV of the Brain-Derived Neurotrophic Factor (BDNF) Gene in Nicotine Dependence and Changes in BDNF Plasma Levels During Smoking Cessation
por: Abdelkhalek, Kerim, et al.
Publicado: (2022)

Nicotine-Induced Effects on Nicotinic Acetylcholine Receptors (nAChRs), Ca(2+) and Brain-Derived Neurotrophic Factor (BDNF) in STC-1 Cells
por: Qian, Jie, et al.
Publicado: (2016)

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2016)

Enantioseparation, quantification, molecular docking and molecular dynamics study of five β-adrenergic blockers on Lux-Cellulose-2 column
por: Saleh, Ola Ahmed, et al.
Publicado: (2023)

ß1-adrenergic blockers preserve neuromuscular function by inhibiting the production of extracellular traps during systemic inflammation in mice
por: Bourcier, Camille H., et al.
Publicado: (2023)

Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin
por: Spincemaille, Pieter, et al.
Publicado: (2014)

A meta-analysis of the vascular-related safety profile and efficacy of α-adrenergic blockers for symptoms related to benign prostatic hyperplasia
por: Nickel, J C, et al.
Publicado: (2008)

β1 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to β-Blocker Therapy and Prognosis
por: Liu, Wen-Nan, et al.
Publicado: (2012)

Mechanisims of asthma and allergic disease – 1069. Down regulation of IL-13 secretion in mononuclear cells by a beta-adrenergic blocker
por: Hajighasemi, Fatemeh
Publicado: (2013)

Clinical Implications of the Change in Glomerular Filtration Rate with Adrenergic Blockers in Patients with Morning Hypertension: The Japan Morning Surge-1 Study
por: Shibasaki, Seiichi, et al.
Publicado: (2013)

Intravenous ephedrine abolished suspected bronchoconstriction during general anesthesia in a patient undergoing beta-adrenergic blocker therapy for hypertension
por: Oshika, Hiroyuki, et al.
Publicado: (2019)

Correction: Nebivolol, a β(1)-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2017)

Alpha-1 Adrenergic Receptor Blockers for the Treatment of Lower Urinary Tract Symptoms in Women: A Systematic Review and Meta-Analysis
por: Kim, Do Kyung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p5adfdiio98avbc0mli5e7f6ra